Flu Testing Platforms

Cardinal Health is prepared to meet the newly updated FDA reclassification requirements and provide you with a portfolio of influenza testing platforms that address a variety of needs. From lateral flow to molecular testing, we have a solution that will ensure FDA compliance.

Alere™ i Influenza A & B

Alere™ i combines the benefits of speed and accuracy on an easy to use system. You no longer need to compromise when testing your patients and making clinical decisions.

Sofia®2 Influenza A+B FIA

Sofia®2 withAdvance Result Technology Delivering accurate, objective and automated results in as few as three minutes.

LifeSign Status Flu A & B

An in vitro rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab and nasal aspirate/wash specimens.

Sofia® Influenza A+B FIA

Quidel’s Sofia Influenza A+B FIA takes lateral flow to a whole new level, utilizing advanced immunofluorescence technology to detect influenza A and influenza B viral nucleoprotein antigens.

Solana® Influenza A+B Assay

Quidel’s Solana Instrument and Solana Influenza A+B Assay offer a scalable and flexible molecular solution for influenza testing that delivers highly accurate molecular results in an actionable timeframe.

Resources

View frequently asked questions about the FDA Reclassification of Rapid Influenza Flu kits (RIDTs).

labXchange

Lab Briefings Webinar Series

Cardinal Health Lab Briefings is an educational webinar series that provides clinical insights, industry information, and hot topic updates across a variety of diagnostic related issues.  Cardinal Health sponsors these webinars with support from leading industry experts and opinion leaders. Receive CE credits by watching past and upcoming webinars at no cost.

Cardinal Health Brand Virtual Lab

Cardinal Health™ Virtual Lab

Explore our virtual lab and you’ll discover the breadth of our Cardinal Health™ Brand offering and how we help thousands of laboratory customers just like you provide better diagnoses and better care. 

What does the FDA reclass of Rapid Influenza Diagnostic Tests mean for you?

With the new guidelines and controls in place, Cardinal Health is well-positioned to meet the newly updated FDA requirements and provide you with a portfolio of influenza testing platforms that address a variety of needs.